Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kei Ikeda

Showing results (61-70 of 168) with videos related to

Pageof 17
Sort By:
Plos One|November 17, 2016
Severity and Diurnal Improvement of Morning Stiffness Independently Associate with Tenosynovitis in Patients with Rheumatoid ArthritisYoshihisa Kobayashi, Kei Ikeda, Takayuki Nakamura, et al.
The Journal of Rheumatology|November 5, 2013
Correlation of radiographic progression with the cumulative activity of synovitis estimated by power Doppler ultrasound in rheumatoid arthritis: difference between patients treated with methotrexate and those treated with biological agentsKei Ikeda, Daiki Nakagomi, Yoshie Sanayama, et al.
Modern Rheumatology|May 23, 2012
Pre-dinner administration increases the efficacy of proton pump inhibitors on refractory GERD symptoms in connective tissue disease patientsArifumi Iwata, Kei Ikeda, Koichi Hirose, et al.
Annals of the Rheumatic Diseases|October 4, 2018
Tocilizumab in patients with adult-onset still's disease refractory to glucocorticoid treatment: a randomised, double-blind, placebo-controlled phase III trialYuko Kaneko, Hideto Kameda, Kei Ikeda, et al.
Rheumatology and Therapy|May 19, 2023
Patient-Physician Communication and Perception of Treatment Goals in Rheumatoid Arthritis: An Online Survey of Patients and PhysiciansShigeki Momohara, Kei Ikeda, Masahiro Tada, et al.
Respiratory Medicine|December 7, 2025
Characterization of Interstitial Lung Disease Subtypes by Bronchoalveolar Lavage Cytokine Profiles: A Cluster-Based ApproachKazuhiro Kurasawa, Ayae Tanaka, Tomoyuki Miyao, et al.
Journal of Immunology (Baltimore, Md. : 1950)|November 9, 2012
β-glucan curdlan induces IL-10-producing CD4+ T cells and inhibits allergic airway inflammationSaki Kawashima, Koichi Hirose, Arifumi Iwata, et al.
International Archives of Allergy and Immunology|June 25, 2008
HMG-CoA reductase inhibitor simvastatin inhibits proinflammatory cytokine production from murine mast cellsShin-ichiro Kagami, Hiroko Kanari, Akira Suto, et al.
RMD Open|February 9, 2023
Prognosis of spontaneous pneumomediastinum occurring in dermatomyositis or polymyositis patients with interstitial lung disease according to antimelanoma differentiation-associated gene 5 antibody status: a retrospective cohort studyKazuya Abe, Shunsuke Furuta, Yoshihisa Kobayashi, et al.
Immunological Medicine|June 26, 2026
Achievement of intermediate treatment targets for Still's disease under tocilizumab treatment: a post-hoc analysis of the phase III trialKoji Suzuki, Hideto Kameda, Kei Ikeda, et al.
Pageof 17

Showing results (61-70 of 168) with videos related to

Sort By:
Pageof 17
Plos One|November 17, 2016
Severity and Diurnal Improvement of Morning Stiffness Independently Associate with Tenosynovitis in Patients with Rheumatoid ArthritisYoshihisa Kobayashi, Kei Ikeda, Takayuki Nakamura, et al.
The Journal of Rheumatology|November 5, 2013
Correlation of radiographic progression with the cumulative activity of synovitis estimated by power Doppler ultrasound in rheumatoid arthritis: difference between patients treated with methotrexate and those treated with biological agentsKei Ikeda, Daiki Nakagomi, Yoshie Sanayama, et al.
Modern Rheumatology|May 23, 2012
Pre-dinner administration increases the efficacy of proton pump inhibitors on refractory GERD symptoms in connective tissue disease patientsArifumi Iwata, Kei Ikeda, Koichi Hirose, et al.
Annals of the Rheumatic Diseases|October 4, 2018
Tocilizumab in patients with adult-onset still's disease refractory to glucocorticoid treatment: a randomised, double-blind, placebo-controlled phase III trialYuko Kaneko, Hideto Kameda, Kei Ikeda, et al.
Rheumatology and Therapy|May 19, 2023
Patient-Physician Communication and Perception of Treatment Goals in Rheumatoid Arthritis: An Online Survey of Patients and PhysiciansShigeki Momohara, Kei Ikeda, Masahiro Tada, et al.
Respiratory Medicine|December 7, 2025
Characterization of Interstitial Lung Disease Subtypes by Bronchoalveolar Lavage Cytokine Profiles: A Cluster-Based ApproachKazuhiro Kurasawa, Ayae Tanaka, Tomoyuki Miyao, et al.
Journal of Immunology (Baltimore, Md. : 1950)|November 9, 2012
β-glucan curdlan induces IL-10-producing CD4+ T cells and inhibits allergic airway inflammationSaki Kawashima, Koichi Hirose, Arifumi Iwata, et al.
International Archives of Allergy and Immunology|June 25, 2008
HMG-CoA reductase inhibitor simvastatin inhibits proinflammatory cytokine production from murine mast cellsShin-ichiro Kagami, Hiroko Kanari, Akira Suto, et al.
RMD Open|February 9, 2023
Prognosis of spontaneous pneumomediastinum occurring in dermatomyositis or polymyositis patients with interstitial lung disease according to antimelanoma differentiation-associated gene 5 antibody status: a retrospective cohort studyKazuya Abe, Shunsuke Furuta, Yoshihisa Kobayashi, et al.
Immunological Medicine|June 26, 2026
Achievement of intermediate treatment targets for Still's disease under tocilizumab treatment: a post-hoc analysis of the phase III trialKoji Suzuki, Hideto Kameda, Kei Ikeda, et al.
Pageof 17